Industrial - Infrastructure Operations
Build Your Comparison
Side-by-side financial analysisStock Comparison
ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Construction Materials
Construction Materials
Construction Materials
Conglomerates
Beverages - Non-Alcoholic
Banks - Diversified
ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||||
|---|---|---|---|---|---|---|---|
| Industry | Industrial - Infrastructure Operations | Construction Materials | Construction Materials | Construction Materials | Conglomerates | Beverages - Non-Alcoholic | Banks - Diversified |
| Market Cap | $6.25B | $69.29B | $36.20B | $34.51B | $4.38B | $350.10B | $873.59B |
| Revenue (TTM) | $2.82B | $49.70B | $8.05B | $6.55B | $1.81B | $49.28B | $280.33B |
| Net Income (TTM) | $223M | $4.58B | $1.12B | $2.53B | $189M | $13.70B | $57.05B |
| Gross Margin | 22.8% | 35.5% | 27.6% | 29.6% | 28.2% | 61.7% | 60.0% |
| Operating Margin | 10.1% | 13.3% | 20.6% | 22.7% | 16.2% | 29.3% | 25.9% |
| Forward P/E | 29.8x | 17.4x | 30.3x | 29.9x | 21.5x | 24.9x | 14.0x |
| Total Debt | $1.52B | $19.70B | $5.41B | $5.32B | $2.74B | $45.49B | $942.38B |
| Cash & Equiv. | $215M | $4.10B | $183M | $67M | $28M | $10.27B | $343.34B |
ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Arcosa, Inc. (ACA) | 100 | 301.8 | +201.8% |
| CRH plc (CRH) | 100 | 302.2 | +202.2% |
| Vulcan Materials Co… (VMC) | 100 | 240.8 | +140.8% |
| Martin Marietta Mat… (MLM) | 100 | 277.0 | +177.0% |
| MDU Resources Group… (MDU) | 100 | 248.8 | +148.8% |
| The Coca-Cola Compa… (KO) | 100 | 182.1 | +82.1% |
| JPMorgan Chase & Co. (JPM) | 100 | 332.4 | +232.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACA has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 12.2%, EPS growth 122.0%, 3Y rev CAGR 8.7%
- 5.3% 10Y total return vs CRH's 279.4%
- 12.2% revenue growth vs MLM's 0.1%
- +41.8% vs MLM's +3.8%
CRH is the clearest fit if your priority is valuation efficiency.
- PEG 0.56 vs MLM's 2.92
VMC doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
MLM is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.90, Low D/E 53.0%, current ratio 3.57x
- 38.7% margin vs ACA's 7.9%
- 13.3% ROA vs JPM's 1.3%, ROIC 7.6% vs 4.5%
MDU ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 37 yrs, beta 0.39, yield 2.5%
- Beta 0.39, yield 2.5%, current ratio 0.84x
- Beta 0.39 vs ACA's 1.40
- 2.5% yield, 37-year raise streak, vs KO's 2.5%
In this particular matchup, KO is outpaced on most metrics by others in the set.
JPM is the clearest fit if your priority is value.
- Lower P/E (14.0x vs 24.9x), PEG 1.08 vs 2.23
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.2% revenue growth vs MLM's 0.1% | |
| Value | Lower P/E (14.0x vs 24.9x), PEG 1.08 vs 2.23 | |
| Quality / Margins | 38.7% margin vs ACA's 7.9% | |
| Stability / Safety | Beta 0.39 vs ACA's 1.40 | |
| Dividends | 2.5% yield, 37-year raise streak, vs KO's 2.5% | |
| Momentum (1Y) | +41.8% vs MLM's +3.8% | |
| Efficiency (ROA) | 13.3% ROA vs JPM's 1.3%, ROIC 7.6% vs 4.5% |
ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM — Financial Metrics
Side-by-side numbers across 7 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 2 of 6 categories
ACA leads 1 • CRH leads 0 • VMC leads 0 • MLM leads 0 • MDU leads 0 • JPM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MLM and KO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 155.2x MDU's $1.8B. MLM is the more profitable business, keeping 38.7% of every revenue dollar as net income compared to ACA's 7.9%. On growth, CRH holds the edge at +170.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.8B | $49.7B | $8.1B | $6.6B | $1.8B | $49.3B | $280.3B |
| EBITDAEarnings before interest/tax | $456M | $9.6B | $2.4B | $2.1B | $503M | $15.5B | $81.4B |
| Net IncomeAfter-tax profit | $223M | $4.6B | $1.1B | $2.5B | $189M | $13.7B | $57.0B |
| Free Cash FlowCash after capex | $225M | $2.9B | $1.1B | $1.0B | -$386M | $12.6B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +22.8% | +35.5% | +27.6% | +29.6% | +28.2% | +61.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +10.1% | +13.3% | +20.6% | +22.7% | +16.2% | +29.3% | +25.9% |
| Net MarginNet income ÷ Revenue | +7.9% | +9.2% | +13.9% | +38.7% | +10.5% | +27.8% | +20.4% |
| FCF MarginFCF ÷ Revenue | +8.0% | +5.9% | +13.9% | +15.8% | -21.4% | +25.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.5% | +170.4% | +7.4% | +0.7% | -10.2% | +12.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -37.5% | +2.1% | +29.9% | +12.2% | -2.5% | +18.2% | +16.0% |
Valuation Metrics
Evenly matched — CRH and JPM each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 15.6x trailing earnings, JPM trades at a 55% valuation discount to VMC's 34.4x P/E. Adjusting for growth (PEG ratio), CRH offers better value at 0.60x vs MLM's 2.97x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Market CapShares × price | $6.3B | $69.3B | $36.2B | $34.5B | $4.4B | $350.1B | $873.6B |
| Enterprise ValueMkt cap + debt − cash | $7.6B | $84.9B | $41.4B | $39.8B | $7.1B | $385.3B | $1.47T |
| Trailing P/EPrice ÷ TTM EPS | 30.03x | 18.82x | 34.36x | 30.44x | 22.55x | 26.76x | 15.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.76x | 17.43x | 30.27x | 29.94x | 21.52x | 24.88x | 14.04x |
| PEG RatioP/E ÷ EPS growth rate | 2.11x | 0.60x | 2.63x | 2.97x | — | 2.39x | 1.20x |
| EV / EBITDAEnterprise value multiple | 13.43x | 11.35x | 17.78x | 18.42x | 14.27x | 26.01x | 18.09x |
| Price / SalesMarket cap ÷ Revenue | 2.17x | 1.85x | 4.56x | 5.27x | 2.34x | 7.30x | 3.12x |
| Price / BookPrice ÷ Book value/share | 2.38x | 2.76x | 4.31x | 3.45x | 1.55x | 10.24x | 2.41x |
| Price / FCFMarket cap ÷ FCF | 35.63x | 27.49x | 31.89x | 35.29x | — | 66.11x | 8.66x |
Profitability & Efficiency
KO leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $7 for MDU. MLM carries lower financial leverage with a 0.53x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), VMC scores 9/9 vs MDU's 3/9, reflecting strong financial health.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.6% | +20.6% | +13.1% | +25.1% | +6.8% | +41.1% | +15.9% |
| ROA (TTM)Return on assets | +4.5% | +8.9% | +6.6% | +13.3% | +2.6% | +13.1% | +1.3% |
| ROICReturn on invested capital | +6.4% | +10.7% | +8.8% | +7.6% | +4.2% | +15.8% | +4.5% |
| ROCEReturn on capital employed | +7.8% | +12.0% | +10.1% | +8.7% | +4.3% | +17.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 9 | 7 | 3 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.58x | 0.77x | 0.63x | 0.53x | 0.99x | 1.33x | 2.60x |
| Net DebtTotal debt minus cash | $1.3B | $15.6B | $5.2B | $5.3B | $2.7B | $35.2B | $599.0B |
| Cash & Equiv.Liquid assets | $215M | $4.1B | $183M | $67M | $28M | $10.3B | $343.3B |
| Total DebtShort + long-term debt | $1.5B | $19.7B | $5.4B | $5.3B | $2.7B | $45.5B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.76x | 6.20x | 4.13x | 6.44x | 2.79x | 10.70x | 0.74x |
Total Returns (Dividends Reinvested)
ACA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRH five years ago would be worth $21,609 today (with dividends reinvested), compared to $16,118 for VMC. Over the past 12 months, ACA leads with a +41.8% total return vs MLM's +3.8%. The 3-year compound annual growth rate (CAGR) favors JPM at 32.5% vs MLM's 10.8% — a key indicator of consistent wealth creation.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +19.3% | -17.4% | -4.3% | -9.5% | +6.2% | +18.4% | -3.0% |
| 1-Year ReturnPast 12 months | +41.8% | +12.9% | +5.6% | +3.8% | +27.8% | +16.2% | +19.4% |
| 3-Year ReturnCumulative with dividends | +74.8% | +123.2% | +37.8% | +36.1% | +93.0% | +44.3% | +132.5% |
| 5-Year ReturnCumulative with dividends | +109.7% | +116.1% | +61.2% | +63.4% | +80.7% | +63.5% | +106.1% |
| 10-Year ReturnCumulative with dividends | +525.2% | +279.4% | +151.4% | +215.3% | +171.9% | +115.2% | +440.5% |
| CAGR (3Y)Annualised 3-year return | +20.5% | +30.7% | +11.3% | +10.8% | +24.5% | +13.0% | +32.5% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than ACA's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.4% from its 52-week high vs CRH's 78.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 1.37x | 0.84x | 0.90x | 0.39x | -0.15x | 0.95x |
| 52-Week HighHighest price in past year | $135.58 | $131.55 | $331.09 | $710.97 | $22.98 | $82.66 | $337.25 |
| 52-Week LowLowest price in past year | $81.91 | $86.83 | $252.35 | $525.83 | $15.76 | $65.35 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +93.9% | +78.8% | +84.3% | +80.5% | +91.3% | +98.4% | +92.7% |
| RSI (14)Momentum oscillator 0–100 | 51.1 | 38.6 | 41.8 | 39.8 | 41.1 | 51.7 | 58.0 |
| Avg Volume (50D)Average daily shares traded | 248K | 4.0M | 980K | 440K | 1.5M | 12.6M | 7.1M |
Analyst Outlook
Evenly matched — MDU and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACA as "Buy", CRH as "Buy", VMC as "Buy", MLM as "Buy", MDU as "Buy", KO as "Buy", JPM as "Buy". Consensus price targets imply 30.8% upside for CRH (target: $136) vs 0.1% for MDU (target: $21). For income investors, MDU offers the higher dividend yield at 2.51% vs ACA's 0.16%.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $140.00 | $135.60 | $322.60 | $684.55 | $21.00 | $86.29 | $338.78 |
| # AnalystsCovering analysts | 8 | 20 | 36 | 40 | 18 | 48 | 61 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +1.2% | +0.7% | +0.6% | +2.5% | +2.5% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 12 | 10 | 37 | 56 | 15 |
| Dividend / ShareAnnual DPS | $0.20 | $1.25 | $1.97 | $3.26 | $0.53 | $2.04 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.7% | +1.2% | +1.3% | 0.0% | +0.2% | +4.0% |
KO leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). ACA leads in 1 (Total Returns). 3 tied.
ACA vs CRH vs VMC vs MLM vs MDU vs KO vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ACA or CRH or VMC or MLM or MDU or KO or JPM a better buy right now?
For growth investors, Arcosa, Inc.
(ACA) is the stronger pick with 12. 2% revenue growth year-over-year, versus 0. 1% for Martin Marietta Materials, Inc. (MLM). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 6x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Arcosa, Inc. (ACA) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACA or CRH or VMC or MLM or MDU or KO or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 6x versus Vulcan Materials Company at 34. 4x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CRH plc wins at 0. 56x versus Martin Marietta Materials, Inc. 's 2. 92x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ACA or CRH or VMC or MLM or MDU or KO or JPM?
Over the past 5 years, CRH plc (CRH) delivered a total return of +116.
1%, compared to +61. 2% for Vulcan Materials Company (VMC). Over 10 years, the gap is even starker: ACA returned +525. 2% versus KO's +115. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACA or CRH or VMC or MLM or MDU or KO or JPM?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
15β versus Arcosa, Inc. 's 1. 40β — meaning ACA is approximately -1046% more volatile than KO relative to the S&P 500. On balance sheet safety, Martin Marietta Materials, Inc. (MLM) carries a lower debt/equity ratio of 53% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — ACA or CRH or VMC or MLM or MDU or KO or JPM?
By revenue growth (latest reported year), Arcosa, Inc.
(ACA) is pulling ahead at 12. 2% versus 0. 1% for Martin Marietta Materials, Inc. (MLM). On earnings-per-share growth, the picture is similar: Arcosa, Inc. grew EPS 122. 0% year-over-year, compared to -42. 0% for Martin Marietta Materials, Inc.. Over a 3-year CAGR, ACA leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACA or CRH or VMC or MLM or MDU or KO or JPM?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus 7. 2% for Arcosa, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 11. 8% for ACA. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ACA or CRH or VMC or MLM or MDU or KO or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CRH plc (CRH) is the more undervalued stock at a PEG of 0. 56x versus Martin Marietta Materials, Inc. 's 2. 92x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 0x forward P/E versus 30. 3x for Vulcan Materials Company — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRH: 30. 8% to $135. 60.
08Which pays a better dividend — ACA or CRH or VMC or MLM or MDU or KO or JPM?
All stocks in this comparison pay dividends.
MDU Resources Group, Inc. (MDU) offers the highest yield at 2. 5%, versus 0. 2% for Arcosa, Inc. (ACA).
09Is ACA or CRH or VMC or MLM or MDU or KO or JPM better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 5% yield, +115. 2% 10Y return). Both have compounded well over 10 years (KO: +115. 2%, ACA: +525. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ACA and CRH and VMC and MLM and MDU and KO and JPM?
These companies operate in different sectors (ACA (Industrials) and CRH (Basic Materials) and VMC (Basic Materials) and MLM (Basic Materials) and MDU (Industrials) and KO (Consumer Defensive) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ACA is a small-cap quality compounder stock; CRH is a mid-cap quality compounder stock; VMC is a mid-cap quality compounder stock; MLM is a mid-cap quality compounder stock; MDU is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; JPM is a large-cap deep-value stock. CRH, VMC, MLM, MDU, KO, JPM pay a dividend while ACA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.